Multi-cohort, Single-arm, Phase II Study of the Efficacy and Side Effects of Cisplatin Plus Gemcitabine in the Treatment of PD1 Failure or Intensive Treatment of Some Rare Tumors

NCT07046650 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

COMBINATION_PRODUCT: cisplatin-based chemotherapy

Sponsor

Sheng Zhang